Preattack Vaccination Against Anthrax May Be Cost-effective in Certain Populations—Reply
Brian P. Schmitt, MD, MPH, Deborah Dobrez, PhD, Demetrios N. Kyriacou, MD, PhD, Jorge Parada, MD, MPH
Arch Intern Med. 2008;168(1):115-115.
Published online January 14, 2008
Select Pricing Criteria:
Choose criteria for pricing info
Want online access for an institution? Learn More/Request Quote >